Skip to main content

Atika Capital Management LLC

Position in GH — Guardant Health, Inc.

CIK 1599731 NEW YORK, NY

Position in GH

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$27,155,428
+$18,749,759 QoQ
Shares Held
181,000
+98.9% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
2.69%
of 13F equity value
Holder Rank
#99
of 593 holders
Holding Since
Jun 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in GH Over Time

Shares Held

Position Value (USD)

Derivatives in GH

reported options exposure · as of Sep 30, 2022
CallValue
$89,033
CallShares
1,654
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

Atika Capital Management LLC holds $46,884,486 across 3 Diagnostics & Research names. GH ranks #1 (57.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 GH
Guardant Health, Inc.
This page
181,000 $27,155,428

All Filings in GH

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $27,155,428 181,000
2026-03-31 $8,405,669 91,000
2025-12-31 $11,031,119 108,000
2025-09-30 $8,309,839 133,000
2025-06-30 $4,641,967 89,200
2025-03-31 $3,642,299 85,500
2022-09-30 $4,306,398 80,000
2022-09-30 $89,033 1,654
2022-06-30 $40,339 1,000
2021-09-30 $10,375,828 83,000
2021-06-30 $10,928,719 88,000
2021-03-31 $13,372,138 87,600
2020-12-31 $12,243,598 95,000
2020-09-30 $8,852,975 79,200
2020-06-30 $6,247,008 77,000